HTS Panama Symposium

Abstracts

Effective Compound Library Storage and Distribution
Rhett Affleck, Nexus BioSystems, Poway, CA

Twenty years in the trenches - The IT Wars Past, Present and Future
Chip Allee, CeuticalSoft

Technology Commercialization
James Baxendale, University of Kanas, Lawrence, KS, USA

Perkin Elmer assay technologies to identify bioactive compounds from biodiversity
Roger Bossé, Perkin Elmer

Advanced Assay Solutions for High Throughput Screening
Michael W. Briggs, PhD, Corning Life Sciences

Overview of Laboratory Automation
Steve Broach, HighRes Biosolutions, Massachusetts

Establishing Cell-Based Assays for Drug Discovery
Rathnam Chaguturu, University of Kansas

Introduction to HTS in Drug Discovery
Rathnam Chaguturu, University of Kansas

HTS: Promises, Successes, Failures and Future Trends
Anuradha Roy, Sitta Sittampalam & Rathnam Chaguturu, University of Kansas, Lawrence, KS (USA)

HTS Assays for Cellular Health & Physiology
Neal Cosby, Promega Corporation

Phenotypic Drug Discovery at Lilly: Teaching an Old Dog New Tricks
Thomas Engler, Lilly Research Laboratories

Society for Biomolecular Sciences
Christine Giordano, Executive Director, SBS

High Content Analysis (HCS) as a Tool for Screening in Cell-based Assays
Scott Keefer, Thermo Fisher Scientific

Computational Approaches for High Throughput Screening: In silico Screening, Hit to Lead QSAR, and Molecular Modeling
Gerry Lushington, University of Kansas

Liquid Handling Technologies and Workstations in HTS
Klaudius Malinowski, ThermoFisher

Signal Detection Platforms for High-throughput Screening
Ramakrishna Seethala, Bristol-Myers Squibb, Princeton, NJ

Fast & Simple Cell and Organism Screening: Whole Well, Cell by Cell, at High Throughput
Chris Shumate, Blueshift Biotechnologies, Inc. (now part of MDS, Inc.)

Statistical Concepts in HTS and SAR Assay Design and Validation
Sitta Sittampalam, University of Kansas Medical Center

Maximizing Laboratory Automation Return on Investment
Ian Yates, Velocity 11